Literature DB >> 31606418

Quality of life and CAR-T cell therapy in children, adolescents, and young adults with haematological malignancies.

Fabio Efficace1, Marco Vignetti2.   

Abstract

Entities:  

Year:  2019        PMID： 31606418     DOI： 10.1016/S1470-2045(19)30641-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment.

Authors:  Quanjun Yang; Juan Hao; Mengyi Chi; Yaxian Wang; Jie Li; Jinlu Huang; Jianping Zhang; Mengqi Zhang; Jin Lu; Shumin Zhou; Ting Yuan; Zan Shen; Shuier Zheng; Cheng Guo
Journal:  Mol Ther       Date:  2022-01-07       Impact factor: 11.454

Review 2.  Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma.

Authors:  Jiaojiao Guo; Qi Tang
Journal:  Cancer Gene Ther       Date:  2021-01-26       Impact factor: 5.854

3.  Assessing health-related quality of life in Chinese children and adolescents with cancer: validation of the DISABKIDS chronic generic module (DCGM-37).

Authors:  Hasan Alelayan; Lizhu Liang; Rui Ye; Jiangnan Meng; Xiaoyan Liao
Journal:  BMC Cancer       Date:  2021-02-27       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.